Quince Therapeutics (QNCX) Stock Chart & Stock Price History $1.61 +0.01 (+0.63%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$1.61 0.00 (0.00%) As of 01/31/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Quince Therapeutics Stock Price Performance 5 Day Performance-6.40%1 Month Performance-13.90%3 Month Performance+4.55%6 Month Performance+116.46%Year-To-Date Performance-13.90%1 Year Performance+22.90% Receive QNCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address QNCX Stock Chart for Saturday, February, 1, 2025 QNCX Chart by TradingView Quince Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/31/2025$1.60$1.61+0.63%$1.69$1.5957,794 shs$70.84 million01/30/2025$1.64$1.60-2.44%$1.66$1.5842,770 shs$70.40 million01/29/2025$1.60$1.64+2.50%$1.64$1.6027,361 shs$72.16 million01/28/2025$1.72$1.60-6.98%$1.78$1.55128,081 shs$70.40 million01/27/2025$1.59$1.72+8.18%$1.74$1.56154,314 shs$69.96 million01/24/2025$1.60$1.59-0.31%$1.65$1.5942,511 shs$69.96 million01/23/2025$1.56$1.60+2.24%$1.63$1.5676,112 shs$70.18 million01/22/2025$1.48$1.56+5.41%$1.68$1.46181,797 shs$68.64 million01/21/2025$1.66$1.48-10.84%$1.68$1.40280,671 shs$65.12 million01/20/2025$1.66$1.66$1.79$1.65184,742 shs$73.04 million Get the Latest News and Ratings for QNCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/17/2025$1.72$1.66-3.49%$1.79$1.65184,742 shs$73.04 million01/16/2025$1.76$1.72-2.27%$1.75$1.6985,069 shs$75.68 million01/15/2025$1.71$1.76+2.92%$1.78$1.7187,074 shs$77.44 million01/14/2025$1.73$1.71-1.16%$1.77$1.70135,630 shs$75.24 million01/13/2025$1.79$1.73-3.35%$1.87$1.70217,892 shs$76.12 million01/10/2025$1.88$1.79-4.79%$1.97$1.75345,507 shs$78.76 million01/09/2025$1.88$1.88$1.95$1.8444,423 shs$82.72 million01/08/2025$1.94$1.88-3.09%$1.95$1.8444,423 shs$82.72 million01/07/2025$1.99$1.94-2.51%$2.01$1.87136,856 shs$85.36 million01/06/2025$1.95$1.99+2.05%$2.04$1.93157,452 shs$87.56 million01/03/2025$1.88$1.95+3.72%$1.95$1.86118,734 shs$85.80 million01/02/2025$1.87$1.88+0.53%$1.97$1.8385,122 shs$82.72 million01/01/2025$1.87$1.87$1.88$1.7468,207 shs$82.28 million12/31/2024$1.85$1.87+1.08%$1.88$1.7468,207 shs$82.28 million Related Companies enGene Stock Price Chart SOPHiA GENETICS Stock Price Chart Atyr PHARMA Stock Price Chart Design Therapeutics Stock Price Chart Immutep Stock Price Chart Eledon Pharmaceuticals Stock Price Chart Contineum Therapeutics Stock Price Chart Y-mAbs Therapeutics Stock Price Chart Heron Therapeutics Stock Price Chart iTeos Therapeutics Stock Price Chart Receive QNCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:QNCX) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump loves DeepSeekPresident Trump could be ecstatic. And it's all thanks to DeepSeek. The secretive Chinese startup just r...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quince Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
